Cited by 955Parkinson's Disease Mechanisms and TreatmentsNerve injury and regenerationNuclear Receptors and Signaling

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Functional recovery in parkinsonian monkeys treated with GDNF

Gash, Don M., Zhang, Zhiming, Ovadia, Aliza, Cass, Wayne A., Yi, Ai, Simmerman, Linda, Russell, Deborah, Martin, David, Lapchak, Paul A., Collins, Frank, Hoffer, Barry J., Gerhard, Greg A.·1996·Nature

DOI 10.1038/380252a0

Open this paper in CoChat — free account

Abstract

Parkinson's disease results from the progressive degeneration of dopamine neurons that innervate the striatum. In rodents, glial-cell-line-derived neurotrophic factor (GDNF) stimulates an increase in midbrain dopamine levels, protects dopamine neurons from some neurotoxins, and maintains injured dopamine neurons. Here we extend the rodent studies to an animal closer to the human in brain organization and function, by evaluating the effects of GDNF injected intracerebrally in rhesus monkeys that have had the symptomatology and pathophysiological features of Parkinson's disease induced by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The recipients of GDNF displayed significant improvements in three of the cardinal symptoms of parkinsonism: bradykinesia, rigidity and postural instability. GDNF administered every four weeks maintained functional recovery. On the lesioned side of GDNF-treated animals, dopamine levels in the midbrain and globus pallidus were twice as high, and nigral dopamine neurons were, on average, 20% larger, with an increased fibre density. The results indicate that GDNF may be of benefit in the treatment of Parkinson's disease.

Integrity signals

Registry

Crossref · 10.1038/380252a0

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Primate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons
Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206
Self-citation
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079
Self-citation
New stereological methods for counting neurons
West, M. J. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90112-o · Cited by 940
Biochemical pathophysiology of Parkinson's disease.
Hornykiewicz, O., & Kish, S. J. (1987) · PubMed · Cited by 850
Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain
Beck, K. D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R. A., Rosenthal, A., & Hefti, F. F. (1995) · Nature · doi:10.1038/373339a0 · Cited by 654
A consideration of neural counting methods
Coggeshall, R. E. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90339-a · Cited by 540
Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo
Hoffer, B. J., Hoffman, A. F., Bowenkamp, K., Huettl, P. F., Hudson, J., Martin, D., Lin, L.-F. H., & Gerhardt, G. A. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90218-6 · Cited by 453
Self-citation
GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo
Kearns, C. M., & Gash, D. M. (1995) · Brain Research · doi:10.1016/0006-8993(94)01366-p · Cited by 379
Self-citation
Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Bankiewicz, K. S., Oldfield, E. H., Chiueh, C. C., Doppman, J. L., Jacobowitz, D. M., & Kopin, I. J. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90431-5 · Cited by 308

Flagged first, then by citations

Show all 22 references

Research works printed but not linked: 2

Jellinger, K. Adv. Neurol. 45, 1–18 (1986).
Hornykiewicz, O. & Kish, S. J. Adv. Neurol. 45, 19–34 (1986).

Sorted by citations

Items 301–400 of 946

Dichotomy of Tyrosine Hydroxylase and Dopamine Regulation between Somatodendritic and Terminal Field Areas of Nigrostriatal and Mesoaccumbens Pathways
Salvatore, M. F., & Pruett, B. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029867 · Cited by 62
Glial-derived neurotrophic factor gene transfer for Parkinson's disease: Anterograde distribution of AAV2 vectors in the primate brain
Kells, A. P., Forsayeth, J., & Bankiewicz, K. S. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.004 · Cited by 63
Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: Role of neuron–glia crosstalk
Saavedra, A., Baltazar, G., Rodrigues‐Santos, P., Carvalho, C. M., & Duarte, E. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.008 · Cited by 61
Neurotrophic Factors in Neurodegeneration
Blesch, A. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00036.x · Cited by 61
Intrastriatal grafting of a GDNF‐producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo
Pérez‐Navarro, E., Arenas, E., Marco, S., & Alberch, J. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00433.x · Cited by 61
Enovin, a member of the glial cell‐line‐derived neurotrophic factor (GDNF) family with growth promoting activity on neuronal cells
Masure, S., Geerts, H., Cik, M., Hoefnagel, E., Kieboom, G. V. D., Tuytelaars, A., Harris, S., Lesage, A. S. J., Leysen, J. E., van der Helm, L., et al. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00925.x · Cited by 61
Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes
Ohta, K., Kuno, S., Mizuta, I., Fujinami, A., Matsui, H., & Ohta, M. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00321-7 · Cited by 61
Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinsons Disease
Hunter, R. L., & Bing, G. (2007) · Current Neuropharmacology · doi:10.2174/157015907780077123 · Cited by 61
Aging Reveals a Role for Nigral Tyrosine Hydroxylase ser31 Phosphorylation in Locomotor Activity Generation
Salvatore, M. F., Pruett, B. S., Spann, S. L., & Dempsey, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008466 · Cited by 60
Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat
Hauber, W. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00102-3 · Cited by 60
Glial cell line–derived neurotrophic factor–levodopa interactions and reduction of side effects in parkinsonian monkeys
Miyoshi, Y., Zhang, Z., Ovadia, A., Lapchak, P. A., Collins, F., Hilt, D. C., LeBel, C. P., Kryscio, R. J., & Gash, D. M. (1997) · Annals of Neurology · doi:10.1002/ana.410420212 · Cited by 60
Self-citation
Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone
Nesti, C., Pardini, C., Barachini, S., D’Alessandro, D., Siciliano, G., Murri, L., Petrini, M., & Vaglini, F. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.042 · Cited by 59
Levodopa/dopamine replacement strategies in Parkinson's disease-Future directions
Olanow, C. W. (2008) · Movement Disorders · doi:10.1002/mds.22061 · Cited by 59
Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease
Stahl, K., Mylonakou, M. N., Skare, Ø., Amiry-Moghaddam, M. R., & Torp, R. (2011) · Brain Research · doi:10.1016/j.brainres.2010.12.090 · Cited by 63
GDNF reverses priming for dyskinesia in MPTP‐treated, l ‐DOPA‐primed common marmosets
Iravani, M. M., Costa, S., Jackson, M. J., Tel, B. C., Cannizzaro, C., Pearce, R. K. B., & Jenner, P. G. (2001) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2001.01408.x · Cited by 59
Glial cell line-derived neurotrophic factor in the substantia nigra from control and parkinsonian brains
Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Kogure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01577-4 · Cited by 59
Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease
Lapchak, P. A., Gash, D. M., Collins, F., Hilt, D. C., Miller, P. J., & Araujo, D. M. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6501 · Cited by 59
Self-citation
Efficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors
Merienne, N., Douce, J. L., Faivre, E., Déglon, N., & Bonvento, G. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00106 · Cited by 58
Effect of Sesamin in Acanthopanax senticosus HARMS on Behavioral Dysfunction in Rotenone-Induced Parkinsonian Rats
Fujikawa, T., Kanada, N., Shimada, A., Ogata, M., Suzuki, I., Hayashi, I., & Nakashima, K. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.169 · Cited by 58
Unilateral intraputaminal glial cell line–derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal
Slevin, J. T., Gash, D. M., Smith, C. D., Gerhardt, G. A., Kryscio, R. J., Chebrolu, H., Walton, A., Wagner, R. P., & Young, A. B. (2006) · Neurosurgical FOCUS · doi:10.3171/foc.2006.20.5.2 · Cited by 58
Self-citation
Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease
Brizard, M., Carcenac, C., Bemelmans, A., Feuerstein, C., Mallet, J. J., & Savasta, M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.06.015 · Cited by 62
Systemic Administration of the Immunophilin Ligand GPI 1046 in MPTP-Treated Monkeys
Emborg, M. E., Shin, P., Roitberg, B. Z., Sramek, J. G., Chu, Y., Stebbins, G. T., Hamilton, J. S., Suzdak, P. D., Steiner, J. P., & Kordower, J. H. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7592 · Cited by 58
Image-guided convection-enhanced delivery of GDNF protein into monkey putamen
Gimenez, F., Krauze, M. T., Valles, F. E., Hadaczek, P., Bringas, J., Sharma, N., Forsayeth, J., & Bankiewicz, K. S. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.023 · Cited by 57
Role of glial cells in neurotoxin-induced animal models of Parkinson’s disease
Yokoyama, H., Uchida, H., Kuroiwa, H., Kasahara, J., & Araki, T. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0424-0 · Cited by 57
GDNF Selectively Induces Microglial Activation and Neuronal Survival in CA1/CA3 Hippocampal Regions Exposed to NMDA Insult through Ret/ERK Signalling
Boscia, F., Esposito, C. L., Crisci, A. D., de Franciscis, V., Annunziato, L., & Cerchia, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006486 · Cited by 57
Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington’s disease
Pérez‐Navarro, E., Åkerud, P., Marco, S., Canals, J. M., Tolosa, E., Arenas, E., & Alberch, J. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00074-9 · Cited by 57
Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line—derived neurotrophic factor
Mehta, V., Hong, M. G. L., Spears, J., & Mendez, I. M. (1998) · Journal of neurosurgery · doi:10.3171/jns.1998.88.6.1088 · Cited by 57
1α,25-Dihydroxyvitamin D3 Protects Dopaminergic Neurons in Rodent Models of Parkinson's Disease through Inhibition of Microglial Activation
Kim, J., Ryu, S.-Y., Yun, I., Kim, W., Lee, K., Park, J., & Kim, Y.-I. (2006) · Journal of Clinical Neurology · doi:10.3988/jcn.2006.2.4.252 · Cited by 56
Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands
Kirik, D., Cederfjäll, E. A., Halliday, G. M., & Petersén, Å. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.09.008 · Cited by 57
Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset
Jenner, P. G., Zeng, B. ‐., Smith, L. A., Pearce, R. K. B., Tel, B. C., Chancharme, L., & Moachon, G. (2000) · Experimental Brain Research · doi:10.1007/s002210000370 · Cited by 56
Neural transplantation for treatment of Parkinson's disease
Borlongan, C. V., & Sanberg, P. R. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02297-3 · Cited by 56
Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets
Costa, S., Iravani, M. M., Pearce, R. K. B., & Jenner, P. G. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00933-x · Cited by 56
Neuroimmunophilin ligands in the treatment of Parkinson's disease
Gold, B. G. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00125-4 · Cited by 56
GDNF: a cytokine at the interface of TGF-βs and neurotrophins
Unsicker, K. (1996) · Cell and Tissue Research · doi:10.1007/s004410050686 · Cited by 56
Xefiltin, a Xenopus laevis neuronal intermediate filament protein, is expressed in actively growing optic axons during development and regeneration
Zhao, Y., & Szaro, B. G. (1997) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19971120)33:6 · Cited by 28
Low-Intensity Pulsed Ultrasound Enhances Neurotrophic Factors and Alleviates Neuroinflammation in a Rat Model of Parkinson’s Disease
Sung, C.-Y., Chiang, P.-K., Tsai, C., & Yang, F. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab201 · Cited by 57
Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro
Eggert, K. M., Schlegel, J., Oertel, W. H., Würz, C., Krieg, J.-C., & Vedder, H. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00443-7 · Cited by 55
Overexpression of glial cell line-derived neurotrophic factor induces genes regulating migration and differentiation of neuronal progenitor cells
Pahnke, J., Mix, E., Knoblich, R., Müller, J. A., Zschiesche, M., Schubert, B., Koczan, D., Bauer, P., Böttcher, T., Thiesen, H., et al. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.03.037 · Cited by 55
Tetanus Toxin C-Fragment: The Courier and the Cure?
Toivonen, J. M., Oliván, S., & Osta, R. (2010) · Toxins · doi:10.3390/toxins2112622 · Cited by 54
Direct convective delivery of adeno-associated virus gene therapy for treatment of neurological disorders
Lonser, R. R., Akhter, A. S., Ząbek, M., Elder, J. B., & Bankiewicz, K. S. (2020) · Journal of neurosurgery · doi:10.3171/2020.4.jns20701 · Cited by 54
Treating Parkinson's disease in the 21st century: Can stem cell transplantation compete?
Buttery, P. C., & Barker, R. A. (2014) · The Journal of Comparative Neurology · doi:10.1002/cne.23577 · Cited by 53
Neuronal activity regulates expression of tyrosine hydroxylase in adult mouse substantia nigra pars compacta neurons
Aumann, T. D., Egan, K., Lim, J. L., Boon, W. C., Bye, C. R., Chua, H. K., Baban, N., Parish, C. L., Bobrovskaya, L., Dickson, P. W., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07151.x · Cited by 53
Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson’s disease
Yue, X., Hariri, D. J., Caballero, B., Zhang, S., Bartlett, M. J., Kaut, O., Mount, D. W., Wüllner, U., Sherman, S. J., & Falk, T. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.038 · Cited by 53
The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson’s disease
Schwenkgrub, J., Zaremba, M., Joniec‐Maciejak, I., Cudna, A., Mirowska-Guzel, D. M., & Kurkowska‐Jastrzębska, I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182019 · Cited by 53
Protein-tyrosine Phosphatase SHP2 Contributes to GDNF Neurotrophic Activity through Direct Binding to Phospho-Tyr687 in the RET Receptor Tyrosine Kinase
Perrinjaquet, M., Vilar, M., & Ibáñez, C. F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.144923 · Cited by 53
Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases
Li, S. H., Abd‐Elrahman, K. S., & Ferguson, S. S. G. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108275 · Cited by 53
Launching invasive, first‐in‐human trials against Parkinson's disease: Ethical considerations
Kimmelman, J., London, A. J., Ravina, B. M., Ramsay, T., Bernstein, M., Fine, A., Stahnisch, F. W., & Emborg, M. E. (2009) · Movement Disorders · doi:10.1002/mds.22712 · Cited by 52
Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson's disease
Pasquarelli, N., Porazik, C., Bayer, H., Buck, E., Schildknecht, S., Weydt, P., Witting, A., & Ferger, B. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.08.003 · Cited by 52
Intraputamenal Infusion of Exogenous Neurturin Protein Restores Motor and Dopaminergic Function in the Globus Pallidus of MPTP-Lesioned Rhesus Monkeys
Grondin, R., Zhang, Z., Ai, Y., Ding, F., Walton, A., Surgener, S. P., Gerhardt, G. A., & Gash, D. M. (2008) · Cell Transplantation · doi:10.3727/096368908784423256 · Cited by 52
Self-citation
Enhancement of Tyrosine Hydroxylase Phosphorylation and Activity by Glial Cell Line-derived Neurotrophic Factor
Kobori, N., Waymire, J. C., Haycock, J. W., Clifton, G. L., & Dash, P. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310734200 · Cited by 52
Behavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets
Dass, B., Iravani, M. M., Jackson, M. J., Engber, T. M., Galdes, A., & Jenner, P. G. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00214-2 · Cited by 52
The effect of dopamine agonists: The expression of GDNF, NGF, and BDNF in cultured mouse astrocytes
Ohta, K., Kuno, S., Inoue, S., Ikeda, E., Fujinami, A., & Ohta, M. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.01.013 · Cited by 55
Cell Transplantation and Gene Therapy in Parkinson's Disease
Wakeman, D. R., Dodiya, H. B., & Kordower, J. H. (2011) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20233 · Cited by 52
Trophic factors for Parkinson's disease: Where are we and where do we go from here?
Paul, G., & Sullivan, A. M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14102 · Cited by 51
The Effects of Dietary Interventions on Brain Aging and Neurological Diseases
Lobo, F., Haase, J., & Brandhorst, S. (2022) · Nutrients · doi:10.3390/nu14235086 · Cited by 54
Rasagiline Promotes Regeneration of Substantia Nigra Dopaminergic Neurons in Post-MPTP-induced Parkinsonism via Activation of Tyrosine Kinase Receptor Signaling Pathway
Mandel, S. A., Sagi, Y., & Amit, T. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9351-8 · Cited by 51
In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered
Airavaara, M., Mijatovic, J., Vihavainen, T., Piepponen, P. T., Saarma, M., & Ahtee, L. (2006) · Synapse · doi:10.1002/syn.20245 · Cited by 51
Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases
Qu, Y., Liu, Y., Noor, A. F., Tran, J., & Li, R. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.250570 · Cited by 51
Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson's disease in marmoset monkeys
Eslamboli, A. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00139-0 · Cited by 51
Intrapallidal dopamine restores motor deficits induced by 6-hydroxydopamine in the rat
Galván, A., Florán, B., Erlij, D., & Aceves, J. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170085 · Cited by 51
Glial Cell Line-Derived Neurotrophic Factor: A Novel Therapeutic Approach to Treat Motor Dysfunction in Parkinson's Disease
Lapchak, P. A., Gash, D. M., Jiao, S., Miller, P. J., & Hilt, D. C. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6384 · Cited by 51
Self-citation
Pallidotomy for Parkinson’s Disease
Lozano, A. M., & Lang, A. E. (1998) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(18)30268-7 · Cited by 51
Effects of glial cell line-derived neurotrophic factor (GDNF) on dopaminergic neurons require concurrent activation of cAMP-dependent signaling pathways
Engele, J., & Franke, B. (1996) · Cell and Tissue Research · doi:10.1007/s004410050692 · Cited by 51
Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease
Sleeman, I. J., Boshoff, E. L., & Duty, S. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.029 · Cited by 51
Electro-acupuncture stimulation acts on the basal ganglia output pathway to ameliorate motor impairment in Parkinsonian model rats.
Jia, J., Li, B., Sun, Z., Yu, F., Wang, X., & Wang, X. (2010) · Behavioral Neuroscience · doi:10.1037/a0018931 · Cited by 50
TGF-β in Dopamine Neuron Development, Maintenance and Neuroprotection
Roussa, E., Halbach, O. V. B. U., & KRIEGLSTEIN, K. G. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0322-8_8 · Cited by 50
Pathogenesis and preclinical course of Parkinson’s disease
Foley, P., & Riederer, P. F. (1999) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6360-3_2 · Cited by 50
From experimentation to the surgical treatment of Parkinson's disease: prelude or suite in basal ganglia research?
Gross, C. E. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00015-5 · Cited by 50
Intranigral or intrastriatal injections of GDNF: effects on monoamine levels and behavior in rats
Martin, D. A., Miller, G., Cullen, T., Fischer, N., Dix, D., & Russell, D. A. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00756-x · Cited by 50
Self-citation
Co-activation of TGF-ß and cytokine signaling pathways are required for neurotrophic functions
Unsicker, K., & KRIEGLSTEIN, K. G. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00033-7 · Cited by 50
Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke
Kuric, E., Wieloch, T. W., & Ruscher, K. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.04.016 · Cited by 52
GDNF revisited: A novel mammalian cell-derived variant form of GDNF increases dopamine turnover and improves brain biodistribution
Grondin, R., Littrell, O. M., Zhang, Z., Ai, Y., Huettl, P. F., Pomerleau, F., Quintero, J. E., Andersen, A. H., Stenslik, M. J., Bradley, L. H., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.014 · Cited by 49
Self-citation
Human gene therapy approaches for the treatment of Parkinson's disease: An overview of current and completed clinical trials
Hitti, F. L., Yang, A. I., Gonzalez‐Alegre, P., & Baltuch, G. H. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.07.018 · Cited by 51
LY503430: Pharmacology, Pharmacokinetics, and Effects in Rodent Models of Parkinson's Disease
O’Neill, M. J., Murray, T. K., Clay, M. P., Lindstrom, T. D., Yang, C. R., & Nisenbaum, E. S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00037.x · Cited by 49
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin
Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2000) · Synapse · doi:10.1002/1098-2396(20010101)39:1 · Cited by 944
A commentary on glial cell line-derived neurotrophic factor (GDNF)
Bohn, M. C. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00280-9 · Cited by 49
Electro-acupuncture stimulation improves motor disorders in Parkinsonian rats
Jia, J., Sun, Z., Li, B., Pan, Y., Wang, H., Wang, X., Yu, F., Liu, L., Zhang, L., & Wang, X. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.024 · Cited by 48
Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons
Piltonen, M., Bespalov, M. M., Ervasti, D., Matilainen, T., Sidorova, Y. A., Rauvala, H., Saarma, M., & Männistö, P. T. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.002 · Cited by 48
Neuroprotective effects of GDNF against 6-OHDA in young and aged rats
Fox, C. M., Gash, D. M., Smoot, M. K., & Cass, W. A. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03270-4 · Cited by 48
Self-citation
Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra
Gervais, J., & Rouillard, C. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000315)35:4 · Cited by 109
Anatomical basis of glial cell line‐derived neurotrophic factor expression in the striatum and related basal ganglia during postnatal development of the rat
Oo, T. F., Ries, V., Cho, J., Kholodilov, N. G., & Burke, R. E. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20463 · Cited by 48
Long‐term neuroprotection and neurorestoration by glial cell‐derived neurotrophic factor microspheres for the treatment of Parkinson's disease
Garbayo, E., Ansorena, E., Lanciego, J. L., Blanco‐Prieto, M. J., & Aymerich, M. S. (2011) · Movement Disorders · doi:10.1002/mds.23793 · Cited by 47
Dopamine Neuron Stimulating Actions of a GDNF Propeptide
Bradley, L. H., Fuqua, J., Hatcher, A. R., Turchan-Cholewo, J. T., Ai, Y., Kelps, K. A., Glass, J. D., He, X., Zhang, Z., Grondin, R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009752 · Cited by 47
Self-citation
Mouse models in neurological disorders: Applications of non-invasive imaging
Waerzeggers, Y., Monfared, P., Viel, T., Winkeler, A., & Jacobs, A. H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.04.009 · Cited by 47
Cellular Interactions that Regulate Programmed Cell Death in the Developing Vertebrate Nervous System
Burek, M. J., & Oppenheim, R. W. (1999) · Humana Press eBooks · doi:10.1007/978-1-4612-1602-5_8 · Cited by 47
Pharmacological characterization of glial cell line-derived neurotrophic factor (GDNF): implications for GDNF as a therapeutic molecule for treating neurodegenerative diseases
Lapchak, P. A., Jiao, S., Miller, P. J., Williams, L. R., Cummins, V., Inouye, G. T., Matheson, C. R., & Yan, Q. (1996) · Cell and Tissue Research · doi:10.1007/s004410050687 · Cited by 47
Self-citation
The potential of GDNF as a treatment for Parkinson's disease
Hurelbrink, C. B., & Barker, R. A. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.09.018 · Cited by 47
Gene Therapy for Neurological Disorders: Challenges and Future Prospects for the Use of Growth Factors for the Treatment of Parkinsons Disease
Manfredsson, F. P., Okun, M. S., & Mandel, R. J. (2009) · Current Gene Therapy · doi:10.2174/156652309789753400 · Cited by 46
GDNF-expressing macrophages restore motor functions at a severe late-stage, and produce long-term neuroprotective effects at an early-stage of Parkinson’s disease in transgenic Parkin Q311X(A) mice
Zhao, Y., Haney, M. J., Jin, Y. S., Uvarov, O., Vinod, N., Lee, Y. Z., Langworthy, B., Fine, J. P., Rodriguez, M., El‐Hage, N., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.027 · Cited by 46
Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine
Shults, C. W., Ray, J., Tsuboi, K., & Gage, F. H. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02900-0 · Cited by 46
Therapeutic Potentials for Glial Cell Line-Derived Neurotrophic Factor (GDNF) Based upon Pharmacological Activities in the CNS
Lapchak, P. A. (1996) · Reviews in the Neurosciences · doi:10.1515/revneuro.1996.7.3.165 · Cited by 46
Self-citation
Intrastriatal Transplantation of Adult Human Neural Crest-Derived Stem Cells Improves Functional Outcome in Parkinsonian Rats
Müller, J., Ossig, C., Greiner, J. F. W., Hauser, S., Fauser, M., Widera, D., Kaltschmidt, C., Storch, A., & Kaltschmidt, B. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0078 · Cited by 45
Inhibition of glutamate and acetylcholine release in behavioral improvement induced by electroacupuncture in parkinsonian rats
Sun, Z., Jia, J., Gong, X., Jia, Y., Deng, J., Wang, X., & Wang, X. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.05.021 · Cited by 45
Characterization of a promoter for the human glial cell line-derived neurotrophic factor gene
Baecker, P. A., Lee, W. H., Verity, A. N., Eglen, R. M., & Johnson, R. M. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00106-0 · Cited by 45
Regulation of Brain-Derived Neurotrophic Factor (BDNF) and Cerebral Dopamine Neurotrophic Factor (CDNF) by Anti-Parkinsonian Drug Therapy In Vivo
Gyárfás, T., Knuuttila, J. E. A., Lindholm, P., Rantamäki, T., & Ċastrén, E. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9458-3 · Cited by 45
Transplantation of glial cell line‐derived neurotrophic factor‐expressing cells into the striatum and nucleus accumbens attenuates acquisition of cocaine self‐administration in rats
Green-Sadan, T., Kinor, N., Roth‐Deri, I., Geffen, R., Schindler, C. J., & Yadid, G. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02943.x · Cited by 45
Neurotrophic Factor–Expressing Mesenchymal Stem Cells Survive Transplantation into the Contused Spinal Cord Without Differentiating into Neural Cells
Rooney, G. E., McMahon, S. S., Ritter, T., Garcia, Y., Moran, C. J., Madigan, N. N., Flügel, A., Dockery, P., O’Brien, T., Howard, L., et al. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0045 · Cited by 45
Recent progress in studies of neurotrophic factors and their clinical implications
Shen, L., Figurov, A., & Lu, B. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050147 · Cited by 45
Activated Immune Cells in Parkinson's Disease
Cao, J., Li, K., & Shen, Y. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9280-9 · Cited by 44
GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice
Chen, C., Li, X., Ge, G., Liu, J., Biju, K. C., Laing, S. D., Qian, Y., Ballard, C., He, Z., Masliah, E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23795-4 · Cited by 44

Authors: Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., Hoffer, B. J., & Gerhard, G. A.
Affiliations: University of Kentucky (US)
ORCID: Gash, Don M.
Zhang, Zhiming
Cass, Wayne A.
Lapchak, Paul A.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1996-03
Volume: 380
Issue: 6571
Pages: 252-255
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/380252a0
OpenAlex: W1971258758
Cited by: 955
References: 22
Citations by year: 2026: 2 · 2025: 12 · 2024: 10 · 2023: 9 · 2022: 20 · 2021: 16 · 2020: 23 · 2019: 18 · 2018: 20 · 2017: 13 · 2016: 21 · 2015: 27 · 2014: 24 · 2013: 30 · 2012: 27
FWCI: 51.18
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords: Parkinson's disease, glial cell line-derived neurotrophic factor, MPTP-induced parkinsonism, rhesus monkeys, dopaminergic neurons, midbrain dopamine, globus pallidus, nigral neurons, bradykinesia, rigidity, postural instability, functional recovery, neuroprotection, neurotrophic therapy
MeSH terms: Animals, Dopamine, Female, Humans, Macaca mulatta, Mesencephalon, Nerve Growth Factors, Nerve Tissue Proteins, Neurons, Parkinson Disease, Recombinant Proteins, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Glial Cell Line-Derived Neurotrophic Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Functional recovery in parkinsonian monkeys treated with GDNF

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks